Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia
Clinical trial NCT03634228 · TERMINATED
Trial details
- NCT number
- NCT03634228
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2022-04-03
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.